Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels (Q72623689)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 March 1995

Language	Label	Description	Also known as
English	Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels	scientific article published on 01 March 1995

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

0 references

Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

F M Sacks

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

J L Rouleau

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

L A Moye

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

M A Pfeffer

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

J W Warnica

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

J M Arnold

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

D T Nash

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

L E Brown

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

F Sestier

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

J Rutherford

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

language of work or name

0 references

publication date

1 March 1995

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

75

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

621-623

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980631-6

7 January 2021

Pravastatin, lipids, and major coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980631-6

7 January 2021

Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980631-6

7 January 2021

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980631-6

7 January 2021

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980631-6

7 January 2021

Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980631-6

7 January 2021

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980631-6

7 January 2021

Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard Atherosclerosis Reversibility Project (HARP) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980631-6

7 January 2021

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980631-6

7 January 2021

Identifiers

10.1016/S0002-9149(99)80631-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7887392%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72623689&oldid=1956728603"